These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31114380)

  • 1. Antitumor effects of Endostar(rh-endostatin) combined with gemcitabine in different administration sequences to treat Lewis lung carcinoma.
    Li Y; Huang P; Peng H; Yue H; Wu M; Liu S; Qin R; Fan J; Han Y
    Cancer Manag Res; 2019; 11():3469-3479. PubMed ID: 31114380
    [No Abstract]   [Full Text] [Related]  

  • 2. Different combination schedules of gemcitabine with endostar affect antitumor efficacy.
    Peng XC; Qiu M; Wei M; Tan BX; Ge J; Zhao Y; Chen Y; Cheng K; Zhou Y; Wu Y; Gong FM; Li Q; Xu F; Bi F; Liu JY
    Cancer Chemother Pharmacol; 2012 Jan; 69(1):239-46. PubMed ID: 21706279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor effects of different administration sequences of cisplatin and Endostar on Lewis lung carcinoma.
    Fan J; DU J; Wu J; Fu S; Hu D; Wan Q
    Oncol Lett; 2015 Feb; 9(2):822-828. PubMed ID: 25624906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of recombinant human endostatin and docetaxel on human umbilical vein endothelial cells in different growth states.
    Xu WJ; Huang C; Wang J; Jiang RC; Wang LC; Lin L; Liu ZJ; Sun BC; Li K
    Chin Med J (Engl); 2011 Sep; 124(18):2883-9. PubMed ID: 22040497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibitory effects of rh-endostatin (YH-16) in combination with radiotherapy on lung adenocarcinoma A549 in mice and the underlying mechanisms.
    Wu H; Deng J; Yu S; Wang X; Chen Y
    J Huazhong Univ Sci Technolog Med Sci; 2010 Feb; 30(1):108-12. PubMed ID: 20155466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human endostatin normalizes tumor vasculature and enhances radiation response in xenografted human nasopharyngeal carcinoma models.
    Peng F; Xu Z; Wang J; Chen Y; Li Q; Zuo Y; Chen J; Hu X; Zhou Q; Wang Y; Ma H; Bao Y; Chen M
    PLoS One; 2012; 7(4):e34646. PubMed ID: 22496834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced antitumor and anti-angiogenic effects of metronomic Vinorelbine combined with Endostar on Lewis lung carcinoma.
    Qin RS; Zhang ZH; Zhu NP; Chen F; Guo Q; Hu HW; Fu SZ; Liu SS; Chen Y; Fan J; Han YW
    BMC Cancer; 2018 Oct; 18(1):967. PubMed ID: 30305062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR/Flk-1 of endothelial cells.
    Ling Y; Yang Y; Lu N; You QD; Wang S; Gao Y; Chen Y; Guo QL
    Biochem Biophys Res Commun; 2007 Sep; 361(1):79-84. PubMed ID: 17644065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of Endostar combined with radiation against human nasopharyngeal carcinoma in mouse xenograft models.
    Zhou J; Wang L; Xu X; Tu Y; Qin S; Yin Y
    Oncol Lett; 2012 Nov; 4(5):976-980. PubMed ID: 23162635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endostar inhibits hypoxia-induced cell proliferation and migration via the hypoxia-inducible factor-1α/vascular endothelial growth factor pathway in vitro.
    Lin K; Ye P; Liu J; He F; Xu W
    Mol Med Rep; 2015 May; 11(5):3780-5. PubMed ID: 25543905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor effect of recombinant human endostatin combined with cisplatin on rats with transplanted Lewis lung cancer.
    Yu ZW; Ju YH; Yang CL; Yu HB; Luo Q; Ma YG; Liu YY
    Asian Pac J Trop Med; 2015 Aug; 8(8):664-7. PubMed ID: 26321522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endostar combined with cisplatin inhibits tumor growth and lymphatic metastasis of lewis lung carcinoma xenografts in mice.
    Dong XP; Xiao TH; Dong H; Jiang N; Zhao XG
    Asian Pac J Cancer Prev; 2013; 14(5):3079-83. PubMed ID: 23803083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PDGFR-β inhibitor slows tumor growth but increases metastasis in combined radiotherapy and Endostar therapy.
    Yin L; He J; Xue J; Na F; Tong R; Wang J; Gao H; Tang F; Mo X; Deng L; Lu Y
    Biomed Pharmacother; 2018 Mar; 99():615-621. PubMed ID: 29653486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endostar, a modified recombinant human endostatin, exhibits synergistic effects with dexamethasone on angiogenesis and hepatoma growth.
    Li XQ; Shang BY; Wang DC; Zhang SH; Wu SY; Zhen YS
    Cancer Lett; 2011 Feb; 301(2):212-20. PubMed ID: 21216091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound-targeted microbubble destruction improved the antiangiogenic effect of Endostar in triple-negative breast carcinoma xenografts.
    Jing Y; Xiu-Juan Z; Hong-Jiao C; Zhi-Kui C; Qing-Fu Q; En-Sheng X; Li-Wu L
    J Cancer Res Clin Oncol; 2019 May; 145(5):1191-1200. PubMed ID: 30805775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of rh-endostar in combination with radiotherapy on rats with lung cancer].
    Du H; Ge W; Li C; Zhao Z; Xu X; Yang F
    Zhongguo Fei Ai Za Zhi; 2010 Apr; 13(4):386-90. PubMed ID: 20677570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human endostatin reduces hypertrophic scar formation in rabbit ear model through down-regulation of VEGF and TIMP-1.
    Wang P; Jiang LZ; Xue B
    Afr Health Sci; 2016 Jun; 16(2):542-53. PubMed ID: 27605970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor interaction of short-course endostatin and ionizing radiation.
    Hanna NN; Seetharam S; Mauceri HJ; Beckett MA; Jaskowiak NT; Salloum RM; Hari D; Dhanabal M; Ramchandran R; Kalluri R; Sukhatme VP; Kufe DW; Weichselbaum RR
    Cancer J; 2000; 6(5):287-93. PubMed ID: 11079167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human recombinant endostatin Endostar attenuates hepatic sinusoidal endothelial cell capillarization in CCl4‑induced fibrosis in mice.
    You Q; Kong LJ; Li FD; Wang HY; Liu DG; Pei FH; Song JT; Xu J; Chen J
    Mol Med Rep; 2015 Oct; 12(4):5594-600. PubMed ID: 26239504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The feasibility of 18F-AlF-NOTA-PRGD2 PET/CT for monitoring early response of Endostar antiangiogenic therapy in human nasopharyngeal carcinoma xenograft model compared with 18F-FDG.
    Cui Y; Liu H; Liang S; Zhang C; Cheng W; Hai W; Yin B; Wang D
    Oncotarget; 2016 May; 7(19):27243-54. PubMed ID: 27029065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.